NCT01376063View on ClinicalTrials.gov

Study to Investigate the Interaction Between FG-4592 and Rosiglitazone in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

May 31, 2010

Study Completion Date

June 30, 2010

Conditions
Healthy Adult Subjects
Interventions
DRUG

FG-4592

"FG-4592 on days 3,5,7,9~Rosiglitazone maleate on days 1 and 9"

Sponsors

Lead Sponsor

FibroGen
All Listed Sponsors
lead

FibroGen

INDUSTRY